423 related articles for article (PubMed ID: 18054800)
1. CDK inhibitors in cancer therapy: what is next?
Malumbres M; Pevarello P; Barbacid M; Bischoff JR
Trends Pharmacol Sci; 2008 Jan; 29(1):16-21. PubMed ID: 18054800
[TBL] [Abstract][Full Text] [Related]
2. Cyclin-dependent kinase modulators: a novel class of cell cycle regulators for cancer therapy.
Senderowicz AM
Cancer Chemother Biol Response Modif; 2001; 19():165-88. PubMed ID: 11686013
[TBL] [Abstract][Full Text] [Related]
3. Cyclin-dependent kinases as targets for cancer therapy.
Senderowicz AM
Cancer Chemother Biol Response Modif; 2002; 20():169-96. PubMed ID: 12703205
[TBL] [Abstract][Full Text] [Related]
4. Novel direct and indirect cyclin-dependent kinase modulators for the prevention and treatment of human neoplasms.
Senderowicz AM
Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S61-73. PubMed ID: 12819936
[TBL] [Abstract][Full Text] [Related]
5. Cyclin-dependent kinase and protein kinase C inhibitors: a novel class of antineoplastic agents in clinical development.
Kaubisch A; Schwartz GK
Cancer J; 2000; 6(4):192-212. PubMed ID: 11038138
[TBL] [Abstract][Full Text] [Related]
6. Small-molecule cyclin-dependent kinase modulators.
Senderowicz AM
Oncogene; 2003 Sep; 22(42):6609-20. PubMed ID: 14528286
[TBL] [Abstract][Full Text] [Related]
7. Cyclin-dependent kinase inhibitors: a survey of recent patent literature.
Galons H; Oumata N; Meijer L
Expert Opin Ther Pat; 2010 Mar; 20(3):377-404. PubMed ID: 20180621
[TBL] [Abstract][Full Text] [Related]
8. [Chemical inhibitors of cyclic-dependent kinases: preclinical and clinical study].
Damiens E; Meijer L
Pathol Biol (Paris); 2000 Apr; 48(3):340-51. PubMed ID: 10858966
[TBL] [Abstract][Full Text] [Related]
9. Small molecule modulators of cyclin-dependent kinases for cancer therapy.
Senderowicz AM
Oncogene; 2000 Dec; 19(56):6600-6. PubMed ID: 11426645
[TBL] [Abstract][Full Text] [Related]
10. [Prevention of chemotherapy-induced alopecia by cyclin-dependant kinase inhibitors].
Meijer L; Knockaert M; Damiens E
Bull Cancer; 2001 Apr; 88(4):347-50. PubMed ID: 11371368
[TBL] [Abstract][Full Text] [Related]
11. Progress in the evaluation of CDK inhibitors as anti-tumor agents.
McInnes C
Drug Discov Today; 2008 Oct; 13(19-20):875-81. PubMed ID: 18639646
[TBL] [Abstract][Full Text] [Related]
12. Recent advances and new directions in the discovery and development of cyclin-dependent kinase inhibitors.
Fischer PM
Curr Opin Drug Discov Devel; 2001 Sep; 4(5):623-34. PubMed ID: 12825457
[TBL] [Abstract][Full Text] [Related]
13. ATP-noncompetitive inhibitors of CDK-cyclin complexes.
Orzáez M; Gortat A; Mondragón L; Bachs O; Pérez-Payá E
ChemMedChem; 2009 Jan; 4(1):19-24. PubMed ID: 19039815
[TBL] [Abstract][Full Text] [Related]
14. CDK inhibitors: from the bench to clinical trials.
Rizzolio F; Tuccinardi T; Caligiuri I; Lucchetti C; Giordano A
Curr Drug Targets; 2010 Mar; 11(3):279-90. PubMed ID: 20210753
[TBL] [Abstract][Full Text] [Related]
15. The use of cyclin-dependent kinase inhibitors alone or in combination with established cytotoxic drugs in cancer chemotherapy.
Grant S; Roberts JD
Drug Resist Updat; 2003 Feb; 6(1):15-26. PubMed ID: 12654284
[TBL] [Abstract][Full Text] [Related]
16. Preclinical and clinical development of cyclin-dependent kinase modulators.
Senderowicz AM; Sausville EA
J Natl Cancer Inst; 2000 Mar; 92(5):376-87. PubMed ID: 10699068
[TBL] [Abstract][Full Text] [Related]
17. Cyclin-dependent kinase inhibitors as anticancer drugs.
Krystof V; Uldrijan S
Curr Drug Targets; 2010 Mar; 11(3):291-302. PubMed ID: 20210754
[TBL] [Abstract][Full Text] [Related]
18. ATP-noncompetitive CDK inhibitors for cancer therapy: an overview.
Abate AA; Pentimalli F; Esposito L; Giordano A
Expert Opin Investig Drugs; 2013 Jul; 22(7):895-906. PubMed ID: 23735075
[TBL] [Abstract][Full Text] [Related]
19. Issues and progress with protein kinase inhibitors for cancer treatment.
Dancey J; Sausville EA
Nat Rev Drug Discov; 2003 Apr; 2(4):296-313. PubMed ID: 12669029
[TBL] [Abstract][Full Text] [Related]
20. Early development of cyclin dependent kinase modulators.
Roy KK; Sausville EA
Curr Pharm Des; 2001 Nov; 7(16):1669-87. PubMed ID: 11562305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
